Table 1.
Characteristics and demographics of participants with the third dose of COVID-19 vaccination, regarding SARS-CoV-2 infection.
| SARS-CoV-2 Infection (−) (n = 91) |
SARS-CoV-2 Infection (+) (n = 58) |
p-Value | |
|---|---|---|---|
| Age | 32.0 (23.0–59.0) | 39.5 (22.0–60.0) | 0.8658 |
| Sex (male: female) | 85:6 | 51:7 | 0.2498 |
| Sampling days after the third vaccination (T1) * | 25.0 (7–32) | 23.5 (14–32) | 0.8318 |
| Sampling days after the third vaccination (T2) * | 129 (103–134) | 129 (113–151) | 0.8725 |
| Post-infection days after the third vaccination | N/A | 106 (77–136) | N/A |
| T2 sampling days after infection | N/A | 22.5 (7–62) | N/A |
Values are presented as the median (range). * Serum samples were collected from the participants 1 month (T1) and 4 months (T2) after the third vaccination. Abbreviation: N/A, not applicable.